CTIC
Closed
Cti Biopharma Corp
9.09
0.00 (0.00%)
Last Update: 26 Jun 2023 16:30:00
Yesterday: 9.09
Day's Range: 9.09 - 9.09
Send
sign up or login to leave a comment!
When Written:
4.2
CTi Biopharma Corp is a biopharmaceutical company that focuses on the development and commercialization of novel targeted therapies for blood-related cancers. The company's lead drug candidate, pacritinib, is a kinase inhibitor that is being developed for the treatment of myelofibrosis, a type of blood cancer. CTi Biopharma Corp is also developing other drug candidates for the treatment of various blood-related cancers. The company was founded in 1991 and is headquartered in Seattle, Washington. CTi Biopharma Corp is publicly traded on the NASDAQ under the ticker symbol "CTIC".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








